Pacific Biosciences of California, Inc. (PACB)
2.21
-0.14
(-5.96%)
USD |
NASDAQ |
Jan 16, 16:00
2.15
-0.06
(-2.71%)
After-Hours: 05:30
Pacific Biosciences of California EPS Diluted (Quarterly): -0.1263 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.5048 |
| Intellia Therapeutics, Inc. | -0.9196 |
| Twist Bioscience Corp. | -0.4491 |
| Beam Therapeutics, Inc. | -1.099 |
| Bruker Corp. | -0.4111 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -38.00M |
| Revenue (Quarterly) | 38.44M |
| Total Expenses (Quarterly) | 76.44M |
| Enterprise Value | 1.068B |
| Gross Profit Margin (Quarterly) | 39.20% |
| Profit Margin (Quarterly) | -98.85% |
| Earnings Yield | -98.45% |
| Normalized Earnings Yield | -102.72 |